Page last updated: 2024-11-03

ono 1078 and Middle Ear Inflammation

ono 1078 has been researched along with Middle Ear Inflammation in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Research Excerpts

ExcerptRelevanceReference
"Conventional treatment for acute otitis media mainly targets bacteria with antibiotics, neglecting to control for mediators of inflammation."2.82The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media. ( Esaki, S; Hamajima, Y; Miyamoto, N; Murakami, S; Nakamura, Y; Nakayama, M; Oshika, M; Sugiyama, K; Suzuki, M; Takagi, I; Yasui, K; Yokota, M, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, Y1
Hamajima, Y1
Suzuki, M1
Esaki, S1
Yokota, M1
Oshika, M1
Takagi, I1
Yasui, K1
Miyamoto, N1
Sugiyama, K1
Nakayama, M1
Murakami, S1

Trials

1 trial available for ono 1078 and Middle Ear Inflammation

ArticleYear
The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media.
    International journal of pediatric otorhinolaryngology, 2016, Volume: 87

    Topics: Acute Disease; Anti-Bacterial Agents; Child; Child, Preschool; Chromones; Disease Progression; Drug

2016